Lloyd Mitchell Segal
CIK 1477123 · PRESIDENT AND CEO · last filed 2026-01-12
Lloyd Mitchell Segal is a PRESIDENT AND CEO who has filed 38 SEC Form 4 insider transactions across 3 companies since 2010. The most recent filing, for AKTS, was dated Jan 12, 2026. Across all open-market trades the lifetime net is −$1.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $475.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$475.3K
3
38
-$1.89M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AKTS | Director | 19,631 | $24.21 | $475.3K | $0 | 1 | 2026-01-12 |
| Repare Therapeutics Inc. (RPTX) Delisted | PRESIDENT AND CEO | 231,952 | $2.65 | $614.7K | -$1.89M | 17 | 2025-03-14 |
| Bausch Health Companies Inc. (BVF) Delisted | Director | — | — | — | $0 | 4 | 2010-07-07 |
Recent Filings
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-12 | AKTS | Conv (C) | +19,631 | $0 | EDGAR |
| 2025-03-14 | Repare Therapeutics Inc. (RPTX) Delisted | Sell (S) | −21,179 | -$24.1K | EDGAR |
| 2025-03-06 | Repare Therapeutics Inc. (RPTX) Delisted | Grant (A) | +40,000 | $0 | EDGAR |
| 2024-04-01 | Repare Therapeutics Inc. (RPTX) Delisted | Sell (S) | −5,141 | -$23.8K | EDGAR |
| 2024-03-27 | Repare Therapeutics Inc. (RPTX) Delisted | Sell (S) | −7,950 | -$37.3K | EDGAR |
| 2024-03-26 | Repare Therapeutics Inc. (RPTX) Delisted | Notice (144) | −99,466 | -$481.4K | EDGAR |
| 2024-03-25 | Repare Therapeutics Inc. (RPTX) Delisted | Notice (144) | −13,091 | -$62.3K | EDGAR |
| 2024-03-04 | Repare Therapeutics Inc. (RPTX) Delisted | Grant (A) | +40,000 | $0 | EDGAR |
| 2023-02-01 | Repare Therapeutics Inc. (RPTX) Delisted | Grant (A) | +78,550 | $0 | EDGAR |
| 2022-01-24 | Repare Therapeutics Inc. (RPTX) Delisted | Exer (M) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.